0001209191-22-032812.txt : 20220531
0001209191-22-032812.hdr.sgml : 20220531
20220531162256
ACCESSION NUMBER: 0001209191-22-032812
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220526
FILED AS OF DATE: 20220531
DATE AS OF CHANGE: 20220531
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GOWEN MAXINE
CENTRAL INDEX KEY: 0001280044
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39231
FILM NUMBER: 22983589
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Passage BIO, Inc.
CENTRAL INDEX KEY: 0001787297
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 822729751
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE COMMERCE SQUARE
STREET 2: 2005 MARKET STREET, 39TH FLOOR
CITY: PHILADELPHIA
STATE: PA
ZIP: 19103
BUSINESS PHONE: 2678660312
MAIL ADDRESS:
STREET 1: ONE COMMERCE SQUARE
STREET 2: 2005 MARKET STREET, 39TH FLOOR
CITY: PHILADELPHIA
STATE: PA
ZIP: 19103
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-05-26
0
0001787297
Passage BIO, Inc.
PASG
0001280044
GOWEN MAXINE
ONE COMMERCE SQUARE
39TH FLOOR
PHILADELPHIA
PA
19103
1
0
0
0
Director Stock Option (Right to Buy)
1.76
2022-05-26
4
A
0
24000
0.00
A
2032-05-25
Common Stock
24000
24000
D
The stock option vests in full on the earlier of: (i) the one year anniversary of the grant date or (ii) the date of the issuer's 2023 Annual Meeting of its stockholders, subject to the reporting person's continuous service to the issuer on such date.
/s/ Edgar Cale, Attorney-in-Fact
2022-05-31